Anti-Human XCR1 Antibodies
AssigneeEisai R&D Management Co., Ltd.
InventorsYoshimasa Sakamoto, Miyuki Nishimura, Tetsu Kawano, Yukihisa Sawa, Toshio Imai
Life of this patent
Estimating the term…
Abstract
An object of the present invention is to provide a monoclonal antibody binding to human XCR1, wherein the antibody binds to linear or discontinuous epitopes which comprise at least three amino acids selected from the group consisting of the 8th, 11th, 12th, 13th, 14th, 16th, 17th, 22nd, 23rd, 176th, and 177th amino acids in the amino acid sequence of SEQ ID NO: 91.
Claims16
An antibody binding to human XCR1, wherein the antibody binds to linear or discontinuous epitopes which comprise at least three amino acids selected from the group consisting of the 8th, 11th, 12th, 13th, 14th, 16th, 17th, 22nd, 23rd, 176th, and 177th amino acids in the amino acid sequence of SEQ ID NO:
- 91.
16-27. (canceled)
Dependencies are inferred from the claim text.